Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 335-347
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.335
Figure 2
Figure 2 Fluorescence in situ hybridization results. By fluorescence in situ hybridization, all tested tumors with 1+ human epidermal growth factor receptor 2 (HER2) staining and 80% of tumors with 2+ staining showed no evidence of HER2 gene amplification (A) whereas 83% of tumors with 3+ HER2 staining harbored HER2 gene amplifications (B).